HEADER TRANSCRIPTION/TBP-ASSOCIATED FACTORS 12-SEP-02 1H3O TITLE CRYSTAL STRUCTURE OF THE HUMAN TAF4-TAF12 (TAFII135-TAFII20) COMPLEX COMPND MOL_ID: 1; COMPND 2 MOLECULE: TRANSCRIPTION INITIATION FACTOR TFIID 135 KDA SUBUNIT; COMPND 3 CHAIN: A, C; COMPND 4 FRAGMENT: HISTONE FOLD DOMAIN, RESIDUES 870-943; COMPND 5 SYNONYM: TAFII-135, TAFII135, TAFII-130, TAFII130, TAF4A, TAF2C, COMPND 6 HTAF4; COMPND 7 ENGINEERED: YES; COMPND 8 MUTATION: YES; COMPND 9 OTHER_DETAILS: N-TERMINAL SELENOMETHIONINE INSERT, UNIFORM SELENO- COMPND 10 METHIONINE LABELING; COMPND 11 MOL_ID: 2; COMPND 12 MOLECULE: TRANSCRIPTION INITIATION FACTOR TFIID 20/15 KDA SUBUNITS; COMPND 13 CHAIN: B, D; COMPND 14 FRAGMENT: HISTONE FOLD DOMAIN, RESIDUES 57-128; COMPND 15 SYNONYM: TAFII-20/TAFII-15, TAFII20/TAFII15, TAF12, TAF2J; COMPND 16 ENGINEERED: YES; COMPND 17 MUTATION: YES; COMPND 18 OTHER_DETAILS: RESIDUES (GLY SER HIS MSE) INSERTED AT THE N-TERMINUS, COMPND 19 REMAINDER OF HISTIDINE-TAG AFTER THROMBIN TREATMENT, UNIFORM SELENO- COMPND 20 METHIONINE LABELING SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 6 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 7 EXPRESSION_SYSTEM_STRAIN: BL21(DE3); SOURCE 8 EXPRESSION_SYSTEM_PLASMID: PACYC-11B; SOURCE 9 OTHER_DETAILS: SYNTHETIC GENE; SOURCE 10 MOL_ID: 2; SOURCE 11 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 12 ORGANISM_COMMON: HUMAN; SOURCE 13 ORGANISM_TAXID: 9606; SOURCE 14 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 15 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 16 EXPRESSION_SYSTEM_STRAIN: BL21(DE3); SOURCE 17 EXPRESSION_SYSTEM_PLASMID: PET-15B; SOURCE 18 OTHER_DETAILS: SYNTHETIC GENE KEYWDS TRANSCRIPTION/TBP-ASSOCIATED FACTORS, TBP-ASSOCIATED FACTORS, TFIID, KEYWDS 2 RNA POLYMERASE II TRANSCRIPTION, HISTONE FOLD DOMAINS, NUCLEAR KEYWDS 3 PROTEIN, TRANSCRIPTION-TBP-ASSOCIATED FACTORS COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR S.WERTEN,A.MITSCHLER,D.MORAS REVDAT 4 24-JUL-19 1H3O 1 REMARK LINK REVDAT 3 24-FEB-09 1H3O 1 VERSN REVDAT 2 03-MAY-05 1H3O 1 JRNL REVDAT 1 26-SEP-02 1H3O 0 JRNL AUTH S.WERTEN,A.MITSCHLER,C.ROMIER,Y.-G.GANGLOFF,S.THUAULT, JRNL AUTH 2 I.DAVIDSON,D.MORAS JRNL TITL CRYSTAL STRUCTURE OF A SUBCOMPLEX OF HUMAN TRANSCRIPTION JRNL TITL 2 FACTOR TFIID FORMED BY TATA BINDING PROTEIN-ASSOCIATED JRNL TITL 3 FACTORS HTAF4 (HTAF(II)135) AND HTAF12 (HTAF(II)20). JRNL REF J.BIOL.CHEM. V. 277 45502 2002 JRNL REFN ISSN 0021-9258 JRNL PMID 12237304 JRNL DOI 10.1074/JBC.M206587200 REMARK 1 REMARK 1 REFERENCE 1 REMARK 1 AUTH Y.-G.GANGLOFF,S.WERTEN,C.ROMIER,L.CARRE,O.POCH,D.MORAS, REMARK 1 AUTH 2 I.DAVIDSON REMARK 1 TITL THE HUMAN TFIID COMPONENTS TAFII135 AND TAFII20 AND THE REMARK 1 TITL 2 YEAST SAGA COMPONENTS ADA1 AND TAFII68 HETERODIMERIZE TO REMARK 1 TITL 3 FORM HISTONE-LIKE PAIRS REMARK 1 REF MOL.CELL.BIOL. V. 20 340 2000 REMARK 1 REFN ISSN 0270-7306 REMARK 1 PMID 10594036 REMARK 2 REMARK 2 RESOLUTION. 2.30 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNS 1.1 REMARK 3 AUTHORS : BRUNGER,ADAMS,CLORE,DELANO,GROS,GROSSE- REMARK 3 : KUNSTLEVE,JIANG,KUSZEWSKI,NILGES,PANNU, REMARK 3 : READ,RICE,SIMONSON,WARREN REMARK 3 REMARK 3 REFINEMENT TARGET : MLF REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.30 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 19.63 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 DATA CUTOFF HIGH (ABS(F)) : 1965882.600 REMARK 3 DATA CUTOFF LOW (ABS(F)) : NULL REMARK 3 COMPLETENESS (WORKING+TEST) (%) : 92.3 REMARK 3 NUMBER OF REFLECTIONS : 12646 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING SET) : 0.226 REMARK 3 FREE R VALUE : 0.272 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.100 REMARK 3 FREE R VALUE TEST SET COUNT : 646 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : 0.011 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 6 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.30 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.44 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 82.00 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 1746 REMARK 3 BIN R VALUE (WORKING SET) : 0.2590 REMARK 3 BIN FREE R VALUE : 0.3320 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 5.00 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 91 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : 0.035 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 2014 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 0 REMARK 3 SOLVENT ATOMS : 158 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 21.90 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 47.40 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -4.44000 REMARK 3 B22 (A**2) : 20.01000 REMARK 3 B33 (A**2) : -15.57000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.30000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.29 REMARK 3 ESD FROM SIGMAA (A) : 0.22 REMARK 3 LOW RESOLUTION CUTOFF (A) : 5.00 REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : 0.38 REMARK 3 ESD FROM C-V SIGMAA (A) : 0.31 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.007 REMARK 3 BOND ANGLES (DEGREES) : 1.100 REMARK 3 DIHEDRAL ANGLES (DEGREES) : 18.30 REMARK 3 IMPROPER ANGLES (DEGREES) : 0.690 REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : RESTRAINED REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : 1.630 ; 1.500 REMARK 3 MAIN-CHAIN ANGLE (A**2) : 2.780 ; 2.000 REMARK 3 SIDE-CHAIN BOND (A**2) : 2.490 ; 2.000 REMARK 3 SIDE-CHAIN ANGLE (A**2) : 3.710 ; 2.500 REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED : FLAT MODEL REMARK 3 KSOL : 0.36 REMARK 3 BSOL : 58.93 REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : PROTEIN_REP.PARAM REMARK 3 PARAMETER FILE 2 : WATER_REP.PARAM REMARK 3 PARAMETER FILE 3 : NULL REMARK 3 TOPOLOGY FILE 1 : PROTEIN.TOP REMARK 3 TOPOLOGY FILE 2 : NULL REMARK 3 TOPOLOGY FILE 3 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NO ELECTRON DENSITY WAS OBSERVED FOR REMARK 3 THE C-TERMINAL PORTION OF HTAF4, RESIDUES 918-943, WHICH IS REMARK 3 THEREFORE ABSENT FROM THE MODEL. THE FACT THAT PART OF THE REMARK 3 PROTEIN COMPLEX DID NOT SHOW UP IN ELECTRON DENSITY MAPS WAS NOT REMARK 3 DUE TO PROTEOLYSIS (AS EVIDENCED BY MASS SPECTROSCOPY OF REMARK 3 REDISSOLVED CRYSTALS), INDICATING THAT THE REGIONS INVOLVED ARE REMARK 3 DISORDERED WITHIN THE CRYSTAL LATTICE. REMARK 4 REMARK 4 1H3O COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 12-SEP-02. REMARK 100 THE DEPOSITION ID IS D_1290011377. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 09-JUN-01 REMARK 200 TEMPERATURE (KELVIN) : 100.0 REMARK 200 PH : 5.25 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : EMBL/DESY, HAMBURG REMARK 200 BEAMLINE : BW7A REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.90730,0.97740 REMARK 200 MONOCHROMATOR : DOUBLE CRYSTAL FOCUSSING REMARK 200 MONOCHROMATOR REMARK 200 OPTICS : PREMIRROR, BENT MIRROR REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : MARRESEARCH REMARK 200 INTENSITY-INTEGRATION SOFTWARE : DENZO REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 24237 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.300 REMARK 200 RESOLUTION RANGE LOW (A) : 20.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 92.3 REMARK 200 DATA REDUNDANCY : 1.500 REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : 0.03400 REMARK 200 FOR THE DATA SET : 19.9000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.30 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.38 REMARK 200 COMPLETENESS FOR SHELL (%) : 90.1 REMARK 200 DATA REDUNDANCY IN SHELL : 1.50 REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : 0.16700 REMARK 200 FOR SHELL : 4.450 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: MAD REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MAD REMARK 200 SOFTWARE USED: SOLVE REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: DATA QUALITY STATISTICS LISTED PERTAIN TO REMOTE REMARK 200 WAVELENGTH DATA (0.90730 A) REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 42.00 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.20 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: PH 5.25 REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: C 1 2 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y,-Z REMARK 290 3555 X+1/2,Y+1/2,Z REMARK 290 4555 -X+1/2,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 3 1.000000 0.000000 0.000000 56.47000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 18.41250 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 4 -1.000000 0.000000 0.000000 56.47000 REMARK 290 SMTRY2 4 0.000000 1.000000 0.000000 18.41250 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 300 REMARK: TWO HETERODIMERS FORMED BY CHAINS A AND B REMARK 300 , OR CHAINSC AND D. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PQS REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PQS REMARK 350 APPLY THE FOLLOWING TO CHAINS: C, D REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 400 REMARK 400 COMPOUND REMARK 400 HTAF4: REMARK 400 MULTIMERIC PROTEIN COMPLEX THAT PLAYS A CENTRAL ROLE IN MEDIATING REMARK 400 PROMOTER RESPONSES TO VARIOUS ACTIVATORS AND REPRESSORS. REMARK 400 REMARK 400 HTAF12: REMARK 400 BELONGS TO THE TAF2J FAMILY. MAKES INTERACTIONS WITH TBP. REMARK 400 TWO ISOFORMS PRODUCED BY ALTERNATIVE INITIATION. REMARK 400 REMARK 400 HTAF4: CONTAINS A SELENOMETHIONINE INSERTION AT N-TERMINUS REMARK 400 MSE 869 CHAINS A AND C. REMARK 400 REMARK 400 HTAF12: CONTAINS A 4 RESIDUE INSERTION (GLY SER HIS MSE) REMARK 400 AT N-TERMINUS RESIDUES 53-56 CHAINS B AND D. REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 ALA A 919 REMARK 465 GLN A 920 REMARK 465 GLN A 921 REMARK 465 LYS A 922 REMARK 465 ASN A 923 REMARK 465 PHE A 924 REMARK 465 SER A 925 REMARK 465 TYR A 926 REMARK 465 LYS A 927 REMARK 465 ASP A 928 REMARK 465 ASP A 929 REMARK 465 ASP A 930 REMARK 465 ARG A 931 REMARK 465 TYR A 932 REMARK 465 GLU A 933 REMARK 465 GLN A 934 REMARK 465 ALA A 935 REMARK 465 SER A 936 REMARK 465 ASP A 937 REMARK 465 VAL A 938 REMARK 465 ARG A 939 REMARK 465 ALA A 940 REMARK 465 GLN A 941 REMARK 465 LEU A 942 REMARK 465 LYS A 943 REMARK 465 GLY B 53 REMARK 465 SER B 54 REMARK 465 ALA C 919 REMARK 465 GLN C 920 REMARK 465 GLN C 921 REMARK 465 LYS C 922 REMARK 465 ASN C 923 REMARK 465 PHE C 924 REMARK 465 SER C 925 REMARK 465 TYR C 926 REMARK 465 LYS C 927 REMARK 465 ASP C 928 REMARK 465 ASP C 929 REMARK 465 ASP C 930 REMARK 465 ARG C 931 REMARK 465 TYR C 932 REMARK 465 GLU C 933 REMARK 465 GLN C 934 REMARK 465 ALA C 935 REMARK 465 SER C 936 REMARK 465 ASP C 937 REMARK 465 VAL C 938 REMARK 465 ARG C 939 REMARK 465 ALA C 940 REMARK 465 GLN C 941 REMARK 465 LEU C 942 REMARK 465 LYS C 943 REMARK 465 GLY D 53 REMARK 465 SER D 54 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 THR A 918 CA C O CB OG1 CG2 REMARK 470 HIS B 55 CG ND1 CD2 CE1 NE2 REMARK 470 THR C 918 CA C O CB OG1 CG2 REMARK 470 HIS D 55 CG ND1 CD2 CE1 NE2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ASP A 895 3.70 -62.93 REMARK 500 GLU B 74 92.14 179.54 REMARK 500 ARG B 106 4.58 -63.82 REMARK 500 SER B 109 -0.60 -145.22 REMARK 500 MSE D 56 106.72 -32.01 REMARK 500 ASP D 71 98.02 -161.09 REMARK 500 REMARK 500 REMARK: NULL REMARK 525 REMARK 525 SOLVENT REMARK 525 REMARK 525 THE SOLVENT MOLECULES HAVE CHAIN IDENTIFIERS THAT REMARK 525 INDICATE THE POLYMER CHAIN WITH WHICH THEY ARE MOST REMARK 525 CLOSELY ASSOCIATED. THE REMARK LISTS ALL THE SOLVENT REMARK 525 MOLECULES WHICH ARE MORE THAN 5A AWAY FROM THE REMARK 525 NEAREST POLYMER CHAIN (M = MODEL NUMBER; REMARK 525 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE REMARK 525 NUMBER; I=INSERTION CODE): REMARK 525 REMARK 525 M RES CSSEQI REMARK 525 HOH C2008 DISTANCE = 7.49 ANGSTROMS REMARK 999 REMARK 999 SEQUENCE REMARK 999 ENGINEERED DELETION MUTANT REMARK 999 REMARK 999 THE HTAF12 POLYPEPTIDE THAT WAS USED FOR CRYSTALLIZATION REMARK 999 CONTAINED THE SEQUENCE GLY-SER-HIS-MET REMARK 999 (ORIGINATING FROM THE EXPRESSION PLASMID) AT ITS N REMARK 999 TERMINUS. NO ELECTRON DENSITY WAS SEEN FOR THE FIRST TWO OF REMARK 999 THESE RESIDUES (GLY-SER, NOT PRESENT IN THE MODEL), WHEREAS REMARK 999 THE THIRD (HIS) HAS BEEN REPLACED BY ALA IN THE MODEL REMARK 999 (NO DENSITY WAS SEEN FOR ITS SIDE CHAIN). DBREF 1H3O A 869 869 PDB 1H3O 1H3O 869 869 DBREF 1H3O A 870 943 UNP O00268 T2D3_HUMAN 870 943 DBREF 1H3O B 53 56 PDB 1H3O 1H3O 53 56 DBREF 1H3O B 57 128 UNP Q16514 T2DA_HUMAN 57 128 DBREF 1H3O C 869 869 PDB 1H3O 1H3O 869 869 DBREF 1H3O C 870 943 UNP O00268 T2D3_HUMAN 870 943 DBREF 1H3O D 53 56 PDB 1H3O 1H3O 53 56 DBREF 1H3O D 57 128 UNP Q16514 T2DA_HUMAN 57 128 SEQRES 1 A 75 MSE PHE LEU LEU GLN ALA PRO LEU GLN ARG ARG ILE LEU SEQRES 2 A 75 GLU ILE GLY LYS LYS HIS GLY ILE THR GLU LEU HIS PRO SEQRES 3 A 75 ASP VAL VAL SER TYR VAL SER HIS ALA THR GLN GLN ARG SEQRES 4 A 75 LEU GLN ASN LEU VAL GLU LYS ILE SER GLU THR ALA GLN SEQRES 5 A 75 GLN LYS ASN PHE SER TYR LYS ASP ASP ASP ARG TYR GLU SEQRES 6 A 75 GLN ALA SER ASP VAL ARG ALA GLN LEU LYS SEQRES 1 B 76 GLY SER HIS MSE VAL LEU THR LYS LYS LYS LEU GLN ASP SEQRES 2 B 76 LEU VAL ARG GLU VAL ASP PRO ASN GLU GLN LEU ASP GLU SEQRES 3 B 76 ASP VAL GLU GLU MSE LEU LEU GLN ILE ALA ASP ASP PHE SEQRES 4 B 76 ILE GLU SER VAL VAL THR ALA ALA CYS GLN LEU ALA ARG SEQRES 5 B 76 HIS ARG LYS SER SER THR LEU GLU VAL LYS ASP VAL GLN SEQRES 6 B 76 LEU HIS LEU GLU ARG GLN TRP ASN MSE TRP ILE SEQRES 1 C 75 MSE PHE LEU LEU GLN ALA PRO LEU GLN ARG ARG ILE LEU SEQRES 2 C 75 GLU ILE GLY LYS LYS HIS GLY ILE THR GLU LEU HIS PRO SEQRES 3 C 75 ASP VAL VAL SER TYR VAL SER HIS ALA THR GLN GLN ARG SEQRES 4 C 75 LEU GLN ASN LEU VAL GLU LYS ILE SER GLU THR ALA GLN SEQRES 5 C 75 GLN LYS ASN PHE SER TYR LYS ASP ASP ASP ARG TYR GLU SEQRES 6 C 75 GLN ALA SER ASP VAL ARG ALA GLN LEU LYS SEQRES 1 D 76 GLY SER HIS MSE VAL LEU THR LYS LYS LYS LEU GLN ASP SEQRES 2 D 76 LEU VAL ARG GLU VAL ASP PRO ASN GLU GLN LEU ASP GLU SEQRES 3 D 76 ASP VAL GLU GLU MSE LEU LEU GLN ILE ALA ASP ASP PHE SEQRES 4 D 76 ILE GLU SER VAL VAL THR ALA ALA CYS GLN LEU ALA ARG SEQRES 5 D 76 HIS ARG LYS SER SER THR LEU GLU VAL LYS ASP VAL GLN SEQRES 6 D 76 LEU HIS LEU GLU ARG GLN TRP ASN MSE TRP ILE MODRES 1H3O MSE A 869 MET SELENOMETHIONINE MODRES 1H3O MSE B 56 MET SELENOMETHIONINE MODRES 1H3O MSE B 83 MET SELENOMETHIONINE MODRES 1H3O MSE B 126 MET SELENOMETHIONINE MODRES 1H3O MSE C 869 MET SELENOMETHIONINE MODRES 1H3O MSE D 56 MET SELENOMETHIONINE MODRES 1H3O MSE D 83 MET SELENOMETHIONINE MODRES 1H3O MSE D 126 MET SELENOMETHIONINE HET MSE A 869 8 HET MSE B 56 8 HET MSE B 83 8 HET MSE B 126 8 HET MSE C 869 8 HET MSE D 56 8 HET MSE D 83 8 HET MSE D 126 8 HETNAM MSE SELENOMETHIONINE FORMUL 1 MSE 8(C5 H11 N O2 SE) FORMUL 5 HOH *158(H2 O) HELIX 1 1 LEU A 872 LYS A 886 1 15 HELIX 2 2 ASP A 895 GLU A 917 1 23 HELIX 3 3 THR B 59 ASP B 71 1 13 HELIX 4 4 ASP B 77 ARG B 106 1 30 HELIX 5 5 GLU B 112 TRP B 124 1 13 HELIX 6 6 LEU C 872 HIS C 887 1 16 HELIX 7 7 PRO C 894 GLU C 917 1 24 HELIX 8 8 THR D 59 GLU D 69 1 11 HELIX 9 9 ASP D 77 ARG D 106 1 30 HELIX 10 10 GLU D 112 TRP D 124 1 13 SHEET 1 AA 2 GLU A 891 LEU A 892 0 SHEET 2 AA 2 THR B 110 LEU B 111 1 N LEU B 111 O GLU A 891 SHEET 1 CA 2 GLU C 891 LEU C 892 0 SHEET 2 CA 2 THR D 110 LEU D 111 1 N LEU D 111 O GLU C 891 LINK C MSE A 869 N PHE A 870 1555 1555 1.33 LINK C HIS B 55 N MSE B 56 1555 1555 1.33 LINK C MSE B 56 N VAL B 57 1555 1555 1.33 LINK C GLU B 82 N MSE B 83 1555 1555 1.33 LINK C MSE B 83 N LEU B 84 1555 1555 1.32 LINK C ASN B 125 N MSE B 126 1555 1555 1.33 LINK C MSE B 126 N TRP B 127 1555 1555 1.32 LINK C MSE C 869 N PHE C 870 1555 1555 1.33 LINK C HIS D 55 N MSE D 56 1555 1555 1.33 LINK C MSE D 56 N VAL D 57 1555 1555 1.33 LINK C GLU D 82 N MSE D 83 1555 1555 1.33 LINK C MSE D 83 N LEU D 84 1555 1555 1.33 LINK C ASN D 125 N MSE D 126 1555 1555 1.33 LINK C MSE D 126 N TRP D 127 1555 1555 1.33 CRYST1 112.940 36.825 73.948 90.00 97.85 90.00 C 1 2 1 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.008854 0.000000 0.001221 0.00000 SCALE2 0.000000 0.027155 0.000000 0.00000 SCALE3 0.000000 0.000000 0.013651 0.00000 MTRIX1 1 0.965260 -0.006950 0.261190 -13.50713 1 MTRIX2 1 -0.010600 -0.999860 0.012570 27.68045 1 MTRIX3 1 0.261060 -0.014900 -0.965210 102.79547 1 HETATM 1 N MSE A 869 20.931 -2.596 71.284 1.00 49.25 N HETATM 2 CA MSE A 869 21.511 -1.245 71.041 1.00 45.54 C HETATM 3 C MSE A 869 21.110 -0.821 69.634 1.00 43.75 C HETATM 4 O MSE A 869 21.084 -1.652 68.719 1.00 42.43 O HETATM 5 CB MSE A 869 23.037 -1.305 71.160 1.00 49.12 C HETATM 6 CG MSE A 869 23.733 0.045 71.081 1.00 51.54 C HETATM 7 SE MSE A 869 25.639 -0.039 71.474 1.00 55.74 SE HETATM 8 CE MSE A 869 25.530 -0.083 73.405 1.00 53.23 C